Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

BACKGROUND: FOLFIRINOX (fluorouracil, folinic acid, irinotecan plus oxaliplatin) is an effective standard first-line treatment option for advanced pancreatic ductal adenocarcinoma (PDAC). There is no clear consensus on the second-line treatment following progression on FOLFIRINOX. In this multicente...

Descripción completa

Detalles Bibliográficos
Autores principales: Chae, Heejung, Jeong, Hyehyun, Cheon, Jaekyung, Chon, Hong Jae, Ryu, Hyewon, Kim, Il-Hwan, Kang, Myoung Joo, Jeong, Jae Ho, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Yoo, Changhoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257856/
https://www.ncbi.nlm.nih.gov/pubmed/32523632
http://dx.doi.org/10.1177/1758835920923424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257856/
https://www.ncbi.nlm.nih.gov/pubmed/32523632
http://dx.doi.org/10.1177/1758835920923424

Ejemplares similares